The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Libtayo
Comments
-
Libtayo (cemiplimab)
I trust by now you have seen positive results. The great worry is that only slightly less than 50% of patients are responders.
i am very fortunate to be a responder, and I am having--knock on wood--some very positive success on Libtayo (cemiplimab) on an 11cm metastasized squamous cell tumor on my psoas muscle. As of month six scan, it has shrunk "significantly" to around 3 cm. An additional tumor in my right axillary has essentially disappeared. My oncologist plans to continue treatment until March 2021 when he will pause treatment, and we'll begin monitoring.
-
Libtayo Ipilimumab Keytruda
PS. If, by chance, you are not too familiar with advances in immunotherapy, this is an excellent place to start, a biography of their inventor, Dr. Jim Allison.
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 455 Bladder Cancer
- 311 Bone Cancers
- 1.6K Brain Cancer
- 28.6K Breast Cancer
- 407 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 802 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards